Suppression of Myeloid PFKFB3‐driven Glycolysis Protects Mice from Choroidal Neovascularization
Zhiping Liu,Xiaoxiao Mao,Qiuhua Yang,Xiaoyu Zhang,Jiean Xu,Qian Ma,Yaqi Zhou,Qingen Da,Yongfeng Cai,Anu Sopeyin,Zheng Dong,Mei Hong,Ruth B. Caldwell,Akrit Sodhi,Yuqing Huo
DOI: https://doi.org/10.1111/bph.15925
IF: 7.3
2022-01-01
British Journal of Pharmacology
Abstract:Background and Purpose: Pathological angiogenesis is a major cause of irreversible blindness in individuals with neovascular age-related macular degeneration (nAMD). Macrophages and microglia (M Phi) contribute to aberrant ocular angiogenesis. However, the role of glucose metabolism of M Phi in nAMD is still undefined. Here, we have investigated the involvement of glycolysis, driven by the kinase/phosphatase PFKFB3, in the development of choroidal neovascularization (CNV). Experimental Approach: CNV was induced in mice with laser photocoagulation. Choroid/retinal pigment epithelium (RPE) complexes and M Phi were isolated for analysis by qRT-PCR, western blot, flow cytometry, immunostaining, metabolic measurements and angiogenesis assays. Key Results: M Phi accumulated within the CNV of murine nAMD models and expressed high levels of glycolysis-related enzymes and M1/M2 polarization markers. This phenotype of hyper-glycolytic and activated M Phi was replicated in bone marrow-derived macrophages stimulated by necrotic RPE in vitro. Myeloid cell- specific knockout of PFKFB3, a key glycolytic activator, attenuated pathological neovascularization in laser-induced CNV, which was associated with decreased expression of M Phi polarization markers and pro-angiogenic factors, along with decreased sprouting of vessels in choroid/RPE complexes. Mechanistically, necrotic RPE increased PFKFB3-driven glycolysis in macrophages, leading to activation of HIF-1 alpha/HIF-2 alpha and NF-kappa B, and subsequent induction of M1/M2 markers and pro-angiogenic cytokines, finally promoting macrophage reprogramming towards an angiogenic phenotype to facilitate development of CNV. The PFKFB3 inhibitor AZ67 also inhibited activation of HIF-1 alpha/HIF-2 alpha and NF-kappa B signalling and almost completely prevented laser-induced CNV in mice. Conclusions and Implications: Modulation of PFKFB3-mediated macrophage glycolysis and activation is a promising strategy for the treatment of nAMD.